欧美午夜精品久久久久免费视-亚洲国产精品无码久久久-鲁鲁狠狠狠7777一区二区-特黄aaaaaaa片免费视频

Welcome to LookChem.com Sign In|Join Free

CAS

  • or
5-Bromo-2-methylbenzoic acid is an organic compound that features a bromine atom at the 5-position and a methyl group at the 2-position on a benzene ring, with a carboxylic acid functional group. It is a white crystalline solid and is commonly used as a building block in the synthesis of various organic and pharmaceutical compounds.

79669-49-1

Post Buying Request

79669-49-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

79669-49-1 Usage

Uses

Used in Organic Synthesis:
5-Bromo-2-methylbenzoic acid is used as a key intermediate in the synthesis of various organic compounds. Its unique structure allows for further functionalization and modification, making it a versatile component in the creation of new molecules with potential applications in various fields.
Used in Pharmaceutical Intermediates:
As a pharmaceutical intermediate, 5-Bromo-2-methylbenzoic acid plays a crucial role in the development of new drugs. Its chemical properties enable the synthesis of bioactive molecules with potential therapeutic effects, contributing to the advancement of medicinal chemistry.
Used in the Synthesis of 5-bromo-2-methyl-N-(quinolin-8-yl)benzamide:
5-Bromo-2-methylbenzoic acid is used as a starting material in the synthesis of 5-bromo-2-methyl-N-(quinolin-8-yl)benzamide, a compound with potential applications in medicinal chemistry and drug discovery.
Used in the Synthesis of (5-Bromo-2-methylphenyl)(thiophen-2-yl)-methanone:
This organic compound is synthesized using 5-Bromo-2-methylbenzoic acid as a precursor. The resulting compound may have potential applications in various fields, such as materials science or pharmaceuticals, due to its unique structure and properties.
Used in the Synthesis of 2-(5-bromo-2-methylbenzyl)-5-(4-fluorophenyl)thiophene:
5-Bromo-2-methylbenzoic acid is also utilized in the synthesis of 2-(5-bromo-2-methylbenzyl)-5-(4-fluorophenyl)thiophene, a compound that may have potential applications in organic electronics, such as in the development of new materials for organic light-emitting diodes (OLEDs) or organic photovoltaics (OPVs).

Synthesis

In a reaction vessel equipped with a mechanical stirrer, a solution of 2-methylbenzoic acid (10.00 g, 73.45 mmol, 1.0 equivalent) in concentrated sulfuric acid (15 mL) at room temperature, bromine (17.6 g, 110.14 mmol, 1. 5 equivalents) was added dropwise over 10 minutes and stirred at 25 ° C. for 20 hours. The reaction solution was injected into ice water (60 ml), and the precipitated solid was filtered, washed with water (20 mL), and air-dried at 60 ° C. overnight to obtain a bromo compound (15.2 g, 97%, addition rate: 95.7).5-Br body / 3-Br body = 62: 38). The obtained crude bromo compound (3 g) was dissolved in ethanol (9 mL) at 70 ° C., cooled to 20 ° C., and stirred at the same temperature for 30 minutes at 10 ° C. or lower for 3 hours. The precipitated crystals were filtered and air-dried at 60 ° C. overnight to obtain 5-Bromo-2-methylbenzoic acid(1.19 g, 5-Br / 3-Br = 91: 9, total yield: 38.5%).

Check Digit Verification of cas no

The CAS Registry Mumber 79669-49-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,9,6,6 and 9 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 79669-49:
(7*7)+(6*9)+(5*6)+(4*6)+(3*9)+(2*4)+(1*9)=201
201 % 10 = 1
So 79669-49-1 is a valid CAS Registry Number.
InChI:InChI=1/C8H7BrO2/c1-5-2-3-6(9)4-7(5)8(10)11/h2-4H,1H3,(H,10,11)

79669-49-1 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H60516)  5-Bromo-2-methylbenzoic acid, 97%   

  • 79669-49-1

  • 1g

  • 323.0CNY

  • Detail
  • Alfa Aesar

  • (H60516)  5-Bromo-2-methylbenzoic acid, 97%   

  • 79669-49-1

  • 5g

  • 1349.0CNY

  • Detail

79669-49-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-Bromo-2-methylbenzoic acid

1.2 Other means of identification

Product number -
Other names 5-bromo-2-methylbenzoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:79669-49-1 SDS

79669-49-1Synthetic route

ortho-methylbenzoic acid
118-90-1

ortho-methylbenzoic acid

5-bromo-2-methylbenzoic acid
79669-49-1

5-bromo-2-methylbenzoic acid

Conditions
ConditionsYield
With 1,3-dibromo-5,5-dimethylimidazolidine-2,4-dione; sulfuric acid88%
Stage #1: ortho-methylbenzoic acid With bromine; iron at 20℃; for 2h;
Stage #2: With hydrogenchloride In methanol; water at 20℃;
19%
With bromine by/at 167 degree melting substance;
5-iodo-2-methylbenzoic acid
54811-38-0

5-iodo-2-methylbenzoic acid

5-bromo-2-methylbenzoic acid
79669-49-1

5-bromo-2-methylbenzoic acid

Conditions
ConditionsYield
With trifluorormethanesulfonic acid; bromine; iron Concentration; Solvent; Molecular sieve;85%
3-Bromo-6-methyl-benzonitrile
156001-51-3

3-Bromo-6-methyl-benzonitrile

5-bromo-2-methylbenzoic acid
79669-49-1

5-bromo-2-methylbenzoic acid

Conditions
ConditionsYield
With sulfuric acid at 160 - 170℃;
4-Methyl-3-nitroanilin
119-32-4

4-Methyl-3-nitroanilin

5-bromo-2-methylbenzoic acid
79669-49-1

5-bromo-2-methylbenzoic acid

Conditions
ConditionsYield
durch Austausch von NH2 gegen Br, Reduktion des Produkts zu 4-Brom-2-amino-toluol und Austausch von NH2 gegen CO2H; by/at 167 degree melting substance;
2,β,β-Tribrom-4-methyl-styrol

2,β,β-Tribrom-4-methyl-styrol

5-bromo-2-methylbenzoic acid
79669-49-1

5-bromo-2-methylbenzoic acid

Conditions
ConditionsYield
With pyridine; potassium permanganate
ortho-methylbenzoic acid
118-90-1

ortho-methylbenzoic acid

bromine
7726-95-6

bromine

5-bromo-2-methylbenzoic acid
79669-49-1

5-bromo-2-methylbenzoic acid

ortho-methylbenzoic acid
118-90-1

ortho-methylbenzoic acid

water
7732-18-5

water

bromine
7726-95-6

bromine

A

5-bromo-2-methylbenzoic acid
79669-49-1

5-bromo-2-methylbenzoic acid

B

2-bromophthalide

2-bromophthalide

Conditions
ConditionsYield
at 140℃;
diethyl ether
60-29-7

diethyl ether

2,4-dibromotoluene
31543-75-6

2,4-dibromotoluene

magnesium

magnesium

5-bromo-2-methylbenzoic acid
79669-49-1

5-bromo-2-methylbenzoic acid

Conditions
ConditionsYield
Behandlung mit CO2;
5-bromo-11-nitro-1.2-dimethyl-benzene

5-bromo-11-nitro-1.2-dimethyl-benzene

5-bromo-2-methylbenzoic acid
79669-49-1

5-bromo-2-methylbenzoic acid

Conditions
ConditionsYield
With potassium permanganate by/at 174-176 degree melting substance;
asymm. bromo-o-xylene

asymm. bromo-o-xylene

5-bromo-2-methylbenzoic acid
79669-49-1

5-bromo-2-methylbenzoic acid

Conditions
ConditionsYield
With nitric acid by/at 174-176 degree melting substance;
diazotized 5-amino-2-methyl-benzoic acid

diazotized 5-amino-2-methyl-benzoic acid

5-bromo-2-methylbenzoic acid
79669-49-1

5-bromo-2-methylbenzoic acid

Conditions
ConditionsYield
With hydrogen bromide; copper(I) bromide
silver salt of/the/ o-toluic acid

silver salt of/the/ o-toluic acid

5-bromo-2-methylbenzoic acid
79669-49-1

5-bromo-2-methylbenzoic acid

Conditions
ConditionsYield
With bromine by/at 167 degree melting substance;
2-benzofuran-1(3H)-one
87-41-2

2-benzofuran-1(3H)-one

5-bromo-2-methylbenzoic acid
79669-49-1

5-bromo-2-methylbenzoic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: hydriodic acid; yellow phosphorus
2: water; bromine / 140 °C
View Scheme
2-cyano-4-nitrotoluene
939-83-3

2-cyano-4-nitrotoluene

5-bromo-2-methylbenzoic acid
79669-49-1

5-bromo-2-methylbenzoic acid

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: palladium; methanol / Hydrogenation
2: aqueous potassium tetrabromocuprate (I)-solution
3: aqueous sulfuric acid / 160 - 170 °C
View Scheme
3-cyano-4-methylaniline
50670-64-9

3-cyano-4-methylaniline

5-bromo-2-methylbenzoic acid
79669-49-1

5-bromo-2-methylbenzoic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: aqueous potassium tetrabromocuprate (I)-solution
2: aqueous sulfuric acid / 160 - 170 °C
View Scheme
ortho-methylbenzoic acid
118-90-1

ortho-methylbenzoic acid

A

3-bromo-2-methylbenzoic acid
76006-33-2

3-bromo-2-methylbenzoic acid

B

5-bromo-2-methylbenzoic acid
79669-49-1

5-bromo-2-methylbenzoic acid

Conditions
ConditionsYield
With bromine; iron at 0 - 20℃;
With bromine; iron at 0 - 20℃;
With bromine; iron at 20℃; for 24h; Title compound not separated from byproducts.;
ortho-methylbenzoic acid
118-90-1

ortho-methylbenzoic acid

3-bromo-4-methylbenzoic acid
7697-26-9

3-bromo-4-methylbenzoic acid

5-bromo-2-methylbenzoic acid
79669-49-1

5-bromo-2-methylbenzoic acid

Conditions
ConditionsYield
With bromine In dichloromethane
With bromine In dichloromethane
5-bromo-2-methylbenzoic acid
79669-49-1

5-bromo-2-methylbenzoic acid

5-bromo-2-methylbenzoyl chloride
21900-41-4

5-bromo-2-methylbenzoyl chloride

Conditions
ConditionsYield
With oxalyl dichloride In dichloromethane; N,N-dimethyl-formamide at 20℃; for 3h; Inert atmosphere;100%
With oxalyl dichloride In dichloromethane; N,N-dimethyl-formamide at 0 - 20℃; for 6h;100%
With thionyl chloride; N,N-dimethyl-formamide for 7h; Reflux;70%
5-bromo-2-methylbenzoic acid
79669-49-1

5-bromo-2-methylbenzoic acid

(5-bromo-2-methylphenyl)methanol
258886-04-3

(5-bromo-2-methylphenyl)methanol

Conditions
ConditionsYield
With dimethylsulfide borane complex In tetrahydrofuran at 0 - 20℃; for 25.5h;100%
With borane-THF In tetrahydrofuran; diethyl ether at 50℃; Inert atmosphere;95%
With borane-THF In tetrahydrofuran; diethyl ether at 50℃; for 3h;95%
methanol
67-56-1

methanol

5-bromo-2-methylbenzoic acid
79669-49-1

5-bromo-2-methylbenzoic acid

methyl 2-methyl-5-bromobenzoate
79669-50-4

methyl 2-methyl-5-bromobenzoate

Conditions
ConditionsYield
Stage #1: methanol; 5-bromo-2-methylbenzoic acid With diazomethyl-trimethyl-silane In hexane at 20℃; for 1.16667h;
Stage #2: With acetic acid In hexane for 0.75h;
99%
Stage #1: 5-bromo-2-methylbenzoic acid With thionyl chloride; N,N-dimethyl-formamide at 0℃; for 3h; Reflux; Inert atmosphere;
Stage #2: methanol
98%
With sulfuric acid at 20℃; for 5h; Time; Cooling with ice; Reflux;97%
5-bromo-2-methylbenzoic acid
79669-49-1

5-bromo-2-methylbenzoic acid

diazomethyl-trimethyl-silane
18107-18-1

diazomethyl-trimethyl-silane

methyl 2-methyl-5-bromobenzoate
79669-50-4

methyl 2-methyl-5-bromobenzoate

Conditions
ConditionsYield
With methanol In diethyl ether; toluene at 0 - 20℃; for 1h;99%
5-bromo-2-methylbenzoic acid
79669-49-1

5-bromo-2-methylbenzoic acid

methyl iodide
74-88-4

methyl iodide

methyl 2-methyl-5-bromobenzoate
79669-50-4

methyl 2-methyl-5-bromobenzoate

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 4h;99%
With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 4h;
2-aminopyridine
504-29-0

2-aminopyridine

5-bromo-2-methylbenzoic acid
79669-49-1

5-bromo-2-methylbenzoic acid

5-bromo-2-methyl-N-(pyridin-2-yl)benzamide

5-bromo-2-methyl-N-(pyridin-2-yl)benzamide

Conditions
ConditionsYield
Stage #1: 5-bromo-2-methylbenzoic acid With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 0.166667h; Inert atmosphere;
Stage #2: 2-aminopyridine With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 30℃; Inert atmosphere;
99%
4-amino-3,5-dimethyl-benzoic acid methyl ester
3095-48-5

4-amino-3,5-dimethyl-benzoic acid methyl ester

5-bromo-2-methylbenzoic acid
79669-49-1

5-bromo-2-methylbenzoic acid

methyl 4-[(5-bromo-2-methyl-benzoyl)amino]-3,5-dimethyl-benzoate
1529760-92-6

methyl 4-[(5-bromo-2-methyl-benzoyl)amino]-3,5-dimethyl-benzoate

Conditions
ConditionsYield
Stage #1: 4-amino-3,5-dimethyl-benzoic acid methyl ester; 5-bromo-2-methylbenzoic acid With N-ethyl-N,N-diisopropylamine In dichloromethane at 0℃; for 0.166667h;
Stage #2: With 2,4,6-tripropyl-1,3,5,2,4,6-trioxatriphosphinane-2,4,6-trioxide In dichloromethane; ethyl acetate at 50℃; for 16h;
97%
5-bromo-2-methylbenzoic acid
79669-49-1

5-bromo-2-methylbenzoic acid

N,O-dimethylhydroxylamine*hydrochloride
6638-79-5

N,O-dimethylhydroxylamine*hydrochloride

C9H10BrNO2

C9H10BrNO2

Conditions
ConditionsYield
Stage #1: 5-bromo-2-methylbenzoic acid With oxalyl dichloride; N,N-dimethyl-formamide In dichloromethane at 20℃;
Stage #2: N,O-dimethylhydroxylamine*hydrochloride With triethylamine In dichloromethane at 0 - 20℃;
97%
ethanol
64-17-5

ethanol

5-bromo-2-methylbenzoic acid
79669-49-1

5-bromo-2-methylbenzoic acid

ethyl 5-bromo-2-methylbenzoate
359629-91-7

ethyl 5-bromo-2-methylbenzoate

Conditions
ConditionsYield
With sulfuric acid In benzene Cooling with ice; Reflux;96%
With sulfuric acid Reflux;95%
With sulfuric acid Reflux;95%
sulfuric acid at 0 - 100℃; for 15h; Inert atmosphere;69%
3,5-dimethyl-4-aminobenzoic acid ethyl ester
3095-47-4

3,5-dimethyl-4-aminobenzoic acid ethyl ester

5-bromo-2-methylbenzoic acid
79669-49-1

5-bromo-2-methylbenzoic acid

methyl 3-[(5-bromo-2-methyl-benzoyl)amino]-2,4-dimethyl-benzoate
1529760-86-8

methyl 3-[(5-bromo-2-methyl-benzoyl)amino]-2,4-dimethyl-benzoate

Conditions
ConditionsYield
Stage #1: 5-bromo-2-methylbenzoic acid With oxalyl dichloride In tetrahydrofuran; dichloromethane; N,N-dimethyl-formamide at 0 - 20℃; for 2h;
Stage #2: 4-amino-3,5-dimethylbenzoic acid ethyl ester With pyridine; dmap In dichloromethane at 0 - 20℃; for 2h;
95.5%
5-bromo-2-methylbenzoic acid
79669-49-1

5-bromo-2-methylbenzoic acid

1-bromo-2-(triisopropylsilyl)acetylene
111409-79-1

1-bromo-2-(triisopropylsilyl)acetylene

3-bromo-6-methyl-2-((triisopropylsilyl)ethynyl)benzoic acid

3-bromo-6-methyl-2-((triisopropylsilyl)ethynyl)benzoic acid

Conditions
ConditionsYield
With bis[dichloro(pentamethylcyclopentadienyl)iridium(III)]; potassium hydrogencarbonate In tert-Amyl alcohol at 30℃; for 24h;95%
With [ruthenium(II)(η6-1-methyl-4-isopropyl-benzene)(chloride)(μ-chloride)]2; potassium carbonate In tert-Amyl alcohol at 80℃; for 24h; Sealed tube; Schlenk technique;88%
2-(4-fluorophenyl)thiophene
58861-48-6

2-(4-fluorophenyl)thiophene

5-bromo-2-methylbenzoic acid
79669-49-1

5-bromo-2-methylbenzoic acid

(5-bromo-2-methylphenyl)[5-(p-fluorophenyl)thiophene-2-yl]methanone
1132832-75-7

(5-bromo-2-methylphenyl)[5-(p-fluorophenyl)thiophene-2-yl]methanone

Conditions
ConditionsYield
Stage #1: 5-bromo-2-methylbenzoic acid With thionyl chloride In dichloromethane; N,N-dimethyl-formamide at 20 - 25℃;
Stage #2: 2-(4-fluorophenyl)thiophene With aluminum (III) chloride In dichloromethane at 0 - 25℃; for 12.5h; Solvent; Reagent/catalyst;
93.2%
Stage #1: 5-bromo-2-methylbenzoic acid With thionyl chloride In dichloromethane; N,N-dimethyl-formamide at 0 - 35℃;
Stage #2: 2-(4-fluorophenyl)thiophene With aluminum (III) chloride In dichloromethane; N,N-dimethyl-formamide at 0 - 35℃;
89%
Stage #1: 5-bromo-2-methylbenzoic acid With oxalyl dichloride; N,N-dimethyl-formamide In dichloromethane at 25 - 30℃; for 0.1h; Inert atmosphere;
Stage #2: 2-(4-fluorophenyl)thiophene With aluminum (III) chloride In dichloromethane at 0 - 15℃; Inert atmosphere;
80.4%
Stage #1: 5-bromo-2-methylbenzoic acid With oxalyl dichloride In dichloromethane at 20℃; for 2h;
Stage #2: 2-(4-fluorophenyl)thiophene With aluminum (III) chloride In dichloromethane at -15 - 35℃; for 4h;
80%
tributyl borane
122-56-5

tributyl borane

5-bromo-2-methylbenzoic acid
79669-49-1

5-bromo-2-methylbenzoic acid

5-butyl-2-methylbenzoic acid

5-butyl-2-methylbenzoic acid

Conditions
ConditionsYield
In tetrahydrofuran Suzuki-Miyaura Coupling; Inert atmosphere;92%
5-bromo-2-methylbenzoic acid
79669-49-1

5-bromo-2-methylbenzoic acid

(3R,4S)-tert-butyl 3-amino-4-fluoropyrrolidine-1-carboxylate

(3R,4S)-tert-butyl 3-amino-4-fluoropyrrolidine-1-carboxylate

tert-butyl (3R,4S)-3-(5-bromo-2-methylbenzamido)-4-fluoropyrrolidine-1-carboxylate

tert-butyl (3R,4S)-3-(5-bromo-2-methylbenzamido)-4-fluoropyrrolidine-1-carboxylate

Conditions
ConditionsYield
With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 2h;92%
5-bromo-2-methylbenzoic acid
79669-49-1

5-bromo-2-methylbenzoic acid

2-[D3]-methyl-5-bromobenzoic acid

2-[D3]-methyl-5-bromobenzoic acid

Conditions
ConditionsYield
With [D]-sodium hydroxide In water-d2 at 20 - 160℃; for 6.5h;90%
5-bromo-2-methylbenzoic acid
79669-49-1

5-bromo-2-methylbenzoic acid

4-Aminobenzonitrile
873-74-5

4-Aminobenzonitrile

C15H11BrN2O

C15H11BrN2O

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; Inert atmosphere;88%
triethyl borane
97-94-9

triethyl borane

5-bromo-2-methylbenzoic acid
79669-49-1

5-bromo-2-methylbenzoic acid

5-ethyl-2-methylbenzoic acid

5-ethyl-2-methylbenzoic acid

Conditions
ConditionsYield
In tetrahydrofuran Suzuki-Miyaura Coupling; Inert atmosphere;87%
N-methylmaleimide
930-88-1

N-methylmaleimide

5-bromo-2-methylbenzoic acid
79669-49-1

5-bromo-2-methylbenzoic acid

C12H12BrNO2

C12H12BrNO2

Conditions
ConditionsYield
With sodium dihydrogenphosphate; [ruthenium(II)(η6-1-methyl-4-isopropyl-benzene)(chloride)(μ-chloride)]2; water at 85℃; for 16h; Green chemistry; chemoselective reaction;84%
5-bromo-2-methylbenzoic acid
79669-49-1

5-bromo-2-methylbenzoic acid

5-bromo-2-methyl-3-nitro-benzoic acid
107650-20-4

5-bromo-2-methyl-3-nitro-benzoic acid

Conditions
ConditionsYield
Stage #1: 5-bromo-2-methylbenzoic acid With sulfuric acid at -10℃; for 0.166667h;
Stage #2: With potassium nitrate at -10℃; for 1h;
82.5%
With sulfuric acid; nitric acid In acetone at -5 - 0℃; for 2.25h; Cooling with acetone-ice;52%
N-acetylpiperidine
13889-98-0

N-acetylpiperidine

5-bromo-2-methylbenzoic acid
79669-49-1

5-bromo-2-methylbenzoic acid

1-[4-(5-bromo-2-methyl-benzoyl)-piperazin-1-yl]-ethanone
1431542-16-3

1-[4-(5-bromo-2-methyl-benzoyl)-piperazin-1-yl]-ethanone

Conditions
ConditionsYield
Stage #1: 5-bromo-2-methylbenzoic acid With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 0.333333h;
Stage #2: N-acetylpiperidine In dichloromethane at 20℃; for 1h;
82%
Stage #1: 5-bromo-2-methylbenzoic acid With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 0.333333h;
Stage #2: N-acetylpiperidine In dichloromethane at 20℃; for 1h;
82%
Stage #1: 5-bromo-2-methylbenzoic acid With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 0.333333h;
Stage #2: N-acetylpiperidine In dichloromethane at 20℃; for 1h;
82%
5-bromo-2-methylbenzoic acid
79669-49-1

5-bromo-2-methylbenzoic acid

methyl 3-amino-2,4-dimethyl-benzoate
24812-89-3

methyl 3-amino-2,4-dimethyl-benzoate

methyl 3-[(5-bromo-2-methyl-benzoyl)amino]-2,4-dimethyl-benzoate
1529760-86-8

methyl 3-[(5-bromo-2-methyl-benzoyl)amino]-2,4-dimethyl-benzoate

Conditions
ConditionsYield
Stage #1: 5-bromo-2-methylbenzoic acid; methyl 3-amino-2,4-dimethyl-benzoate With N-ethyl-N,N-diisopropylamine In dichloromethane at 0℃; for 0.166667h;
Stage #2: With 2,4,6-tripropyl-1,3,5,2,4,6-trioxatriphosphinane-2,4,6-trioxide In dichloromethane; ethyl acetate at 50℃; for 16h;
80%
4-amino-3,5-dimethyl-benzoic acid methyl ester
3095-48-5

4-amino-3,5-dimethyl-benzoic acid methyl ester

5-bromo-2-methylbenzoic acid
79669-49-1

5-bromo-2-methylbenzoic acid

methyl 3-[(5-bromo-2-methyl-benzoyl)amino]-2,4-dimethyl-benzoate
1529760-86-8

methyl 3-[(5-bromo-2-methyl-benzoyl)amino]-2,4-dimethyl-benzoate

Conditions
ConditionsYield
Stage #1: 4-amino-3,5-dimethyl-benzoic acid methyl ester; 5-bromo-2-methylbenzoic acid With N-ethyl-N,N-diisopropylamine In dichloromethane for 0.166667h;
Stage #2: With 2,4,6-tripropyl-1,3,5,2,4,6-trioxatriphosphinane-2,4,6-trioxide In dichloromethane; ethyl acetate at 50℃; for 16h;
80%
2-amino-1-(4-(dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)-3-phenylpropan-1-one

2-amino-1-(4-(dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)-3-phenylpropan-1-one

5-bromo-2-methylbenzoic acid
79669-49-1

5-bromo-2-methylbenzoic acid

5-bromo-N-(1-(4-(dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)-1-oxo-3-phenylpropan-2-yl)-2-methylbenzamide

5-bromo-N-(1-(4-(dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)-1-oxo-3-phenylpropan-2-yl)-2-methylbenzamide

Conditions
ConditionsYield
With O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 12h; Inert atmosphere;79%
5-bromo-2-methylbenzoic acid
79669-49-1

5-bromo-2-methylbenzoic acid

5-bromo-2-methylbenzoyl fluoride

5-bromo-2-methylbenzoyl fluoride

Conditions
ConditionsYield
With (3,3-difluorocycloprop-1-ene-1,2-diyl)dibenzene In dichloromethane at 50℃; for 4h; Inert atmosphere; Schlenk technique; Sealed tube;79%
Multi-step reaction with 2 steps
1: N,N-dimethyl-formamide; oxalyl dichloride / dichloromethane / 2 h / 0 - 20 °C
2: cesium fluoride / acetonitrile / 80 °C
View Scheme
3,5-dimethyl-4-aminobenzoic acid ethyl ester
3095-47-4

3,5-dimethyl-4-aminobenzoic acid ethyl ester

5-bromo-2-methylbenzoic acid
79669-49-1

5-bromo-2-methylbenzoic acid

ethyl 4-[(5-bromo-2-methyl-benzoyl)amino]-3,5-dimethyl-benzoate
1529761-04-3

ethyl 4-[(5-bromo-2-methyl-benzoyl)amino]-3,5-dimethyl-benzoate

Conditions
ConditionsYield
Stage #1: 5-bromo-2-methylbenzoic acid With oxalyl dichloride In tetrahydrofuran; dichloromethane at 0 - 20℃; for 2h;
Stage #2: 4-amino-3,5-dimethylbenzoic acid ethyl ester With pyridine; dmap In dichloromethane at 0 - 20℃; for 5h;
75.2%
5-bromo-2-methylbenzoic acid
79669-49-1

5-bromo-2-methylbenzoic acid

acetonitrile
75-05-8

acetonitrile

2-acetyl-6-bromoisoindolin-1-one

2-acetyl-6-bromoisoindolin-1-one

Conditions
ConditionsYield
With iron(III)-acetylacetonate; copper(II) nitrate; Selectfluor at 80℃; for 8h; Schlenk technique; Inert atmosphere;74%
5-bromo-2-methylbenzoic acid
79669-49-1

5-bromo-2-methylbenzoic acid

3-chlorophenylboronic acid
63503-60-6

3-chlorophenylboronic acid

3'-chloro-4-methylbiphenyl-3-carboxylic acid
1482106-89-7

3'-chloro-4-methylbiphenyl-3-carboxylic acid

Conditions
ConditionsYield
With tetrakis(triphenylphosphine) palladium(0); sodium carbonate In water; acetonitrile at 80℃; for 18h; Inert atmosphere;73.2%
With tetrakis(triphenylphosphine) palladium(0); sodium carbonate In water; acetonitrile at 80℃; for 18h; Inert atmosphere;73.2%
5-bromo-2-methylbenzoic acid
79669-49-1

5-bromo-2-methylbenzoic acid

5-bromo-2-(difluoromethyl)benzoic acid
1630983-04-8

5-bromo-2-(difluoromethyl)benzoic acid

Conditions
ConditionsYield
With sodium persulfate; silver nitrate; Selectfluor In water; acetonitrile at 80℃; for 3h; Inert atmosphere; Schlenk technique; Cooling with liquid nitrogen;73%

79669-49-1Relevant articles and documents

METHOD FOR PRODUCING 5-BROMO-2-ALKYLBENZOIC ACID

-

Paragraph 0068-0070; 0079-0082, (2021/09/03)

PROBLEM TO BE SOLVED: To provide a method for producing 5-bromo-2-alkylbenzoic acid, which is useful as a synthetic intermediate of a drug substance such as an antidiabetic, in an industrially inexpensive and efficient manner. SOLUTION: The present disclosure provides a method for producing 5-bromo-2-alkylbenzoic acid by bringing 2-alkylbenzoic acid and bromine into contact with each other, in the presence of sulfuric acid. Particularly if 2-alkylbenzoic acid is 2-methylbenzoic acid, the inventive production method enables efficient production of 5-bromo-2-methylbenzoic acid to be a raw material for producing canagliflozin, one of antidiabetics. SELECTED DRAWING: None COPYRIGHT: (C)2021,JPOandINPIT

Synthesis and evaluation of a novel series of 6-bromo-1-cyclopentyl-1H-indazole-4-carboxylic acid-substituted amide derivatives as anticancer, antiangiogenic, and antioxidant agents

Sawant, Ajay S.,Kamble, Sonali S.,Pisal, Parshuram M.,Meshram, Rohan J.,Sawant, Sanjay S.,Kamble, Vilas A.,Kamble, Vinod T.,Gacche, Rajesh N.

, p. 17 - 32 (2019/11/14)

A series of novel indazole derivatives has been synthesized and evaluated for anticancer, antiangiogenic, and antioxidant activities. The capability of the synthesized compounds 11a–x to hinder the viability of three human cancer cells lines, HEP3BPN 11 (liver), MDA 453 (breast), and HL 60 (leukemia), were assessed by using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction assay. Among the compounds 11a–x screened, 11c and 11d showed the higher inhibitory activity on the viability of HEP3BPN 11 (liver), when compared with the standard methotrexate. These compounds were further tested to evaluate their potential to inhibit the proangiogenic cytokines associated with tumor development. Compound 11c was found to be a potent antiangiogenic agent against TNFα, VEGF, and EGF, whereas 11d showed potent antiangiogenic activity against TNFα, VEGF, IGF1, TGFb, and leptin inhibition. All the compounds 11a–x were screened for their antioxidant activities using 2,2-diphenyl-1-picryl hydrazine (DPPH), hydroxyl (OH), and superoxide radical (SOR) scavenging activity. Compounds 11n, 11p, 11q, and 11v have shown significant OH radical scavenging activities, also compounds 11c, 11h, and 11k were found to have a DPPH radical scavenging activity and compounds 11a and 11m exhibited better SOR scavenging activity when compared with the reference compound ascorbic acid. In silico molecular docking analysis revealed important structural insights behind observed anti TNFα effect by present indazole compounds.

Synthesis, computational, and spectroscopic analysis of tunable highly fluorescent BN-1,2-azaborine derivatives containing the N-BOH moiety

Saint-Louis, Carl Jacky,Shavnore, Renée N.,McClinton, Caleb D. C.,Wilson, Julie A.,Magill, Lacey L.,Brown, Breanna M.,Lamb, Robert W.,Webster, Charles Edwin,Schrock, Alan K.,Huggins, Michael T.

, p. 10172 - 10183 (2017/12/26)

Nine new polycyclic aromatic BN-1,2-azaborine analogues containing the N-BOH moiety were synthesized using a convenient two-step, one-pot procedure. Characterization of the prepared compounds show the luminescence wavelength and the quantum yields of the azaborines were tunable by controlling the power and location of the donor and acceptor substituents on the chromophore. UV-visible spectroscopy and density functional theory (DFT) computations revealed that the addition of electron-donating moieties to the isoindolinone hemisphere raised the energy of the HOMO, resulting in the reduction of the HOMO-LUMO gap. The addition of an electron-accepting moiety to the isoindolinone hemisphere and an electron-donating group to the boronic acid hemisphere decreased the HOMO-LUMO gap considerably, leading to emission properties from partial intramolecular charge transfer (ICT) states. The combined effect of an acceptor on the isoindolinone side and a donor on the boronic acid side (strong acceptor-π-donor) gave the most red-shifted absorption. The polycyclic aromatic BN-1,2-azaborines emitted strong fluorescence in solution and in the solid-state with the largest red-shifted emission at 640 nm and a Stokes shift of Δλ = 218 nm, or Δν = 8070 cm-1.

Process for synthesizing card Geleg only (by machine translation)

-

, (2016/12/01)

The invention discloses a process for synthesizing card Geleg only, in order to 2?Methyl benzoic acid as starting material, use of improvised catalyst, reaction to produce the iodine iodate a in the middle, or in 2?Methyl benzoic acid as starting material, the metal reagent and under the action of catalyst, by adding liquid bromine, synthetic intermediates b; optionally intermediate one or intermediate two acylation reaction with thionyl chloride, to Friedel-crafts reaction produce intermediate three; in order to ALPHA?D?Glucose as raw material, with the reaction protection of all hydroxyl after pivalyl chloride, and then with zinc bromide, trimethyl silane reaction produce intermediate four; three intermediate the intermediate body, connecting delivery into intermediate five; finally under acidic conditions to remove the acyl special fifth heavenly stem, produce the target compound. card Geleg only of the present invention new process for the synthesis of high yield, mild condition, safety and reliability, is suitable for industrial production, raw material is cheap and easy to obtain, it is beneficial to control the production cost. (by machine translation)

Series of structural and functional models for the ES (enzyme-substrate) complex of the Co(II)-containing quercetin 2,3-dioxygenase

Sun, Ying-Ji,Huang, Qian-Qian,Zhang, Jian-Jun

supporting information, p. 2932 - 2942 (2014/04/03)

A series of mononuclear CoII-flavonolate complexes [Co IILR(fla)] (LRH = 2-{[bis(pyridin-2-ylmethyl) amino]methyl}-p/m-R-benzoic acid; R = p-OMe (1), p-Me (2), m-Br (4), and m-NO2 (5); fla = flavonolate) were designed and synthesized as structural and functional models for the ES (enzyme-substrate) complexes to mimic the active site of the Co(II)-containing quercetin 2,3-dioxygenase (Co-2,3-QD). The metal center Co(II) ion in each complex shows a similar distorted octahedral geometry. The model complexes display high enzyme-type dioxygenation reactivity (oxidative O-heterocyclic ring opening of the coordinated substrate flavonolate) at low temperature, presumably due to the attached carboxylate group in the ligands. The reactivity exhibits a substituent group dependent order of -OMe (1) > -Me (2) > -H (3)14b > -Br (4) > -NO2 (5), and the Hammett plot is linear (ρ = -0.78). This can be explained as the electronic nature of the substituent group in the ligands may influence the conformation and redox potential of the bound flavonolate and finally bring different reactivity. The structures, properties, and reactivity of the model complexes show some dependence on the substituent group in the supporting model ligands, and there is some relationship among them. This study is the first example of a series of structural and functional ES models of Co-2,3-QD, with focus on the effects of the electronic nature of substituted groups and the carboxylate group of the ligands to the dioxygenation reactivity, that will provide important insights into the structure-property-reactivity relationship and the catalytic role of Co-2,3-QD.

Synthesis and characterization of π-extended porphyrins as potential precursors for the formation of columnar mesophases: Design principles for columnar mesophases need revision?

Herzog, Beat,Neier, Reinhard

experimental part, p. 29 - 44 (2011/06/18)

A series of meso-a bridged extended porphyrins substituted with long aliphatic chains were synthesized and fully characterized. Two different synthetic strategies were tested to obtain the target structures. The synthetic steps were optimized in order to obtain scalable routes for the production of sufficient quantities of η-extended porphyrins for material science studies. The porphyrins were obtained either as free bases or complexed with Ni II or CuII. UV-Vis spectroscopy and polarized light microscopy was used for the analysis of the material properties of the η-extended porphyrins. The results obtained with our compounds are not compatible with the results reported in the literature. ARKAT-USA, Inc.

INHIBITORS OF DIACYLGLYCEROL ACYL TRANSFERASE

-

Example 1, (2011/07/30)

The present invention relates to heterocyclic compounds in all their stereoisomeric and tautomeric forms; and their pharmaceutically acceptable salts, pharmaceutically acceptable solvates and pharmaceutically acceptable polymorphs. The invention also relates to processes for the manufacture of the heterocyclic compounds and to pharmaceutical compositions containing them. The said compounds and their pharmaceutical compositions are useful in the prevention and treatment of diseases or disorders mediated by diacylglycerol acyltransferase (DGAT), particularly DGAT1. The present invention further provides a method of treatment of such diseases or disorders by administering a therapeutically effective amount of said compounds or their pharmaceutical compositions, to a mammal in need thereof.

Synthesis of N-methyl-6-heterocyclic-1-oxoisoindoline derivatives by microwave assisted buchwald-hartwig amination

Kishor Kumar,Vijay Kumar,Naik, Nagaraja

scheme or table, p. 1108 - 1113 (2012/06/15)

An rapid and efficient microwave assisted Pd(II) catalyzed protocol for the preparation of N-methyl-6-heterocyclic-1-oxoisoindoline derivatives by Buchwald-Hartwig amination with an overall yield 68-85% has been described.

MODULATORS OF ATP-BINDING CASSETTE-TRANSPORTERS

-

Page/Page column 55, (2009/06/27)

Compounds of the present invention, and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (""ABC"") transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (""CFTR""). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention.

Synthetic strategies to derivatizable triphenylamines displaying high two-photon absorption

Lartia, Remy,Allain, Clemence,Bordeau, Guillaume,Schmidt, Falk,Fiorini-Debuisschert, Celine,Charra, Fabrice,Teulade-Fichou, Marie-Paule

, p. 1732 - 1744 (2008/09/18)

(Chemical Equation Presented) A versatile synthetic strategy to access a set of highly fluorescent π-conjugated triphenylamines bearing a functional linker at various positions on one phenyl ring is described. These compounds were designed for large two-photon absorption (2PA) and in particular for labeling of biomolecules. The monoderivatized trisformylated or trisiodinated intermediates described herein allow introduction of a large variety of electron-withdrawing groups required for large 2PA as well as a panel of chemical functions suitable for coupling to biomolecules. The monoderivatized three-branched compounds and in particular the benzothiazole (TP-3Bz) series show remarkable linear (high extinction coefficients and high quantum yield) and nonlinear (high 2-photon cross sections) optical properties. Interestingly the presence of functional side chains does not disturb the two-photon absorption. Finally, monoderivatized two-branched derivatives also appear to be valuable candidates. Altogether the good optical properties of the new derivatizable π-conjugated TPA combined with their small size and their compatibility with bioconjugation protocols suggest that they represent a new chemical class of labels potentially applicable for the tracking of biomolecules using two-photon scanning microscopy.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 79669-49-1